Adial Pharmaceuticals Inc (ADIL)
1.045
0.00 (0.00%)
USD |
NASDAQ |
Jul 03, 16:00
1.01
-0.04
(-3.35%)
After-Hours: 05:45
Adial Pharmaceuticals Research and Development Expense (Annual): 1.267M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.267M |
| December 31, 2022 | 1.950M |
| December 31, 2021 | 8.396M |
| December 31, 2020 | 5.853M |
| December 31, 2019 | 3.966M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.3685M |
| December 31, 2017 | 0.1821M |
| December 31, 2016 | 0.1461M |
| December 31, 2015 | 0.3221M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.267M
Minimum
2023
8.396M
Maximum
2021
4.286M
Average
3.966M
Median
2019
Research and Development Expense (Annual) Benchmarks
| BioSig Technologies Inc | 5.092M |
| Allurion Technologies Inc | 27.69M |
| Monogram Technologies Inc | 10.59M |
| Palatin Technologies Inc | 22.63M |
| Galectin Therapeutics Inc | 32.13M |